Tata India Pharma & Healthcare Fund Direct Growth
Tata India Pharma & Healthcare Fund Direct Growth: NAV ₹39.85, 3Y return 18.38%, 5Y 15.80%, AUM ₹1,541 Cr, expense ratio 1.09%, iNVESTT rating 4/5. Returns vs index, rolling returns, holdings, Direct vs Regular and peers, by a SEBI Registered Research Analyst.
Key facts
- NAV
- ₹39.8534 (19 Nov 2026)
- 1-year return
- 10.72%
- 3-year return (CAGR)
- 18.38%
- 5-year return (CAGR)
- 15.80%
- Fund size (AUM)
- ₹1,541 Cr
- Expense ratio
- 1.09%
- Exit load
- 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
- Minimum investment
- Rs.5000 & in multiples of Re.1/- thereafter.
- Category
- Sectoral Fund
- Benchmark
- BSE Healthcare TRI
- Riskometer
- Very High Risk
- Fund manager
- Rajat Srivastava
- Launch date
- 4 Dec 2015
- iNVESTT rating
- 4 out of 5
Frequently asked questions
What is the NAV of Tata India Pharma & Healthcare Fund Direct Growth today?
The NAV of Tata India Pharma & Healthcare Fund Direct Growth is ₹39.8534 as of 19 Nov 2026.
What are the returns of Tata India Pharma & Healthcare Fund Direct Growth?
10.72% over 1 year, 18.38% a year over 3 years, 15.80% a year over 5 years. Past returns do not guarantee future returns; compare them with the benchmark and rolling returns on this page.
What is the expense ratio of Tata India Pharma & Healthcare Fund Direct Growth?
The expense ratio (TER) is 1.09% a year.
What is the AUM (fund size) of Tata India Pharma & Healthcare Fund Direct Growth?
Tata India Pharma & Healthcare Fund Direct Growth manages ₹1,541 Cr.
Is there an exit load on Tata India Pharma & Healthcare Fund Direct Growth?
Exit load: 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment..
How risky is Tata India Pharma & Healthcare Fund Direct Growth?
Its SEBI riskometer is "Very High Risk" and it is in the Sectoral Fund category.
What is the benchmark of Tata India Pharma & Healthcare Fund Direct Growth?
The benchmark is BSE Healthcare TRI. This page compares the fund with its benchmark's total-return index (TRI).
What is the iNVESTT rating of Tata India Pharma & Healthcare Fund Direct Growth?
4 out of 5. iNVESTT rating: where the fund ranks in its category over 1, 3 and 5 years (3 and 5 years count most). Top fifth = 5 stars. A past-performance measure, not a recommendation.
Research by iNVESTT, a SEBI Registered Research Analyst (INH000010858). Data from AMFI. Mutual fund investments are subject to market risks; past performance does not guarantee future returns.